From: miR-520d-5p can reduce the mutations in hepatoma cancer cells and iPSCs-derivatives
MT (1–65) | |
GL00026 (66–90) | |
GL000229 (91–108) | |
GL000231 (109–126) | |
GL000239 (127–129) | |
GL000201 (130–131) | |
GL000246 (132) | |
GL000249 (133) | |
GL000238 (134–138) | |
GL000234 (139–160) | |
GL000232 (161–163) | |
GL000240 (164–165) | |
GL000241 (166–180) | |
GL000243 (181–183) | |
GL000230 (184–250) | |
GL000237 (251–385) | |
GL000204 (386) | |
GL000198 (387–394) | |
GL000208 (395–402) | |
GL000191 (403–414) | |
GL000228 (415–420) | |
GL000214 (421–566) | |
GL000221 (567–573) | |
GL000209 (574–643) | |
GL000218 (644–722) | |
GL000220 (723–1345) | |
GL000213 (1346–1347) | |
GL000211 (1348) | |
GL000199 (1349–1356) | |
GL000217 (1357–1365) | |
GL000216 (1366–1395) | |
GL000205 (1396–1547) | |
GL000219 (1548–1614) | |
GL000224 (1615–1729) | |
GL000223 (1730–1746) | |
GL000195 (1747–1966) | |
GL000212 (1967–2107) | |
GL000222 (2108–2124) | |
GL000193 (2125–2146) | |
GL000194 (2147–2186) | |
GL000225 (2187–2267) | |
GL000192 (2268) |